FOMAT is expanding its ophthalmology clinical trials network in Central California through a new partnership with Dr. Daniel R. Agarwal, an ophthalmologist specializing in retina and vitreous care at San Luis Obispo Eye Associates. This collaboration reflects FOMAT’s commitment to bringing innovative therapies to underserved regions and diverse patient populations across the state. Ophthalmology clinical trials represent a critical frontier in addressing eye conditions that affect millions of patients worldwide, and FOMAT is positioned to lead this effort in Central California.
Dr. Agarwal, a graduate of Weill Cornell Medicine, brings over a decade of experience treating cataracts, retinal detachment, diabetic retinopathy, macular degeneration, and complex uveitis. He is one of the only physicians on the Central Coast treating complex uveitis, making him a unique and valuable asset to FOMAT’s growing research network. His deep understanding of vitreoretinal diseases and his longstanding relationships with patients in the region make him an ideal principal investigator for this initiative.
Ophthalmology Clinical Trials: Expanding Access in Central California
Through this partnership, Dr. Agarwal’s practice will participate in ophthalmology clinical trials for the first time, giving patients local access to cutting edge treatments not previously available in San Luis Obispo. FOMAT provides the clinical trial management infrastructure while Dr. Agarwal contributes his specialized medical expertise, creating a model that benefits patients, sponsors, and investigators alike.
For patients, this means access to innovative therapies for conditions such as retinal detachment, diabetic retinopathy, macular degeneration, and uveitis, without needing to travel outside their community. FOMAT’s community based model ensures that participation is accessible and supported from screening through study completion. Patients who previously had no access to experimental treatments now have an opportunity to contribute to research that could shape the future of ophthalmology care.
“This collaboration allows us to provide our patients with access to groundbreaking treatments and to delve deeper into innovative therapeutic areas in ophthalmology,” said Dr. Agarwal. “It is a significant step forward for our practice and for advancing patient care in the community.”
A Strategic Expansion for Sponsors and CROs
For sponsors and CROs conducting ophthalmology clinical trials, this partnership opens access to a highly specialized investigator and an underserved patient population in Central California. FOMAT’s proven site management model ensures fast startup, consistent enrollment, and data quality across its network of 26 investigator sites statewide. The combination of a specialized investigator, an established patient base, and FOMAT’s operational infrastructure makes this site a strong candidate for sponsors seeking efficient and high quality ophthalmology trial execution.
Simon Corman, COO of FOMAT, stated: “This partnership underscores our mission to broaden access to clinical trials while addressing unmet medical needs in key therapeutic areas like ophthalmology. Dr. Agarwal’s extensive expertise and dedication to patient care align perfectly with our goals, and together we will make advanced treatments accessible to more patients in Central California.”
The benefits of this partnership extend beyond providing state of the art treatments to patients. It also fosters a collaborative environment where clinical and research expertise are combined to drive innovation in ophthalmology. This integration enhances the potential for significant advancements in treating eye conditions that affect millions of patients worldwide.
About San Luis Obispo Eye Associates
San Luis Obispo Eye Associates has served the Central Coast for over 30 years, offering advanced cataract surgery, vision correction, and comprehensive eye care from locations in San Luis Obispo and Templeton. Their commitment to excellence and patient-centered care makes them an ideal research partner.
About FOMAT
FOMAT is a network of 26 investigator sites across California, focused on serving diverse patient populations for multiple therapeutic areas of study. By collaborating with community-based research physicians, we ensure inclusive access to phase I-IV clinical studies, supported by state-of-the-art facilities and a team of dedicated professionals.
Read full Press Release